{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:51:55Z","timestamp":1791499915678,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40249-016-0140-y","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T14:55:44Z","timestamp":1462373744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy"],"prefix":"10.1186","volume":"5","author":[{"given":"Liesbeth","family":"Mieras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van Brakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"Bratschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Cambau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle","family":"Cavaliero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Kasang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geethal","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Reichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hendrik","family":"Richardus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saunderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Wai","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"issue":"4","key":"140_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4269\/ajtmh.2005.72.443","volume":"72","author":"MI Bakker","year":"2005","unstructured":"Bakker MI, Hatta M, Kwenang A, Van Benthem BHB, Van Beers SM, Klatser PR, et al. Prevention of leprosy using rifampicin as chemoprophylaxis. Am J Trop Med Hyg. 2005;72(4):443\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"7647","key":"140_CR2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","volume":"336","author":"FJ Moet","year":"2008","unstructured":"Moet FJ, Pahan D, Oskam L, Richardus JH, COLEP Study Group. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ. 2008;336(7647):761\u20134.","journal-title":"BMJ"},{"issue":"2","key":"140_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/jinf.2000.0698","volume":"41","author":"CM Smith","year":"2000","unstructured":"Smith CM, Smith WC. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy. J Infect. 2000;41(2):137\u201342.","journal-title":"J Infect"},{"key":"140_CR4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/1471-2334-13-456","volume":"13","author":"RA Richardus","year":"2013","unstructured":"Richardus RA, Alam K, Pahan D, et al. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study). BMC Infect Dis. 2013;13:456.","journal-title":"BMC Infect Dis"},{"key":"140_CR5","unstructured":"WHO | Tuberculosis. http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/ . Accessed 17 June 2015."},{"issue":"8","key":"140_CR6","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1073\/pnas.0511240103","volume":"103","author":"S Gagneux","year":"2006","unstructured":"Gagneux S, DeRiemer K, Van T, Kato-Maeda M, De Jong BC, Narayanan S, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006;103(8):2869\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"140_CR7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/AEM.20.5.810-814.1970","volume":"20","author":"HL David","year":"1970","unstructured":"David HL. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol. 1970;20(5):810\u20134.","journal-title":"Appl Microbiol"},{"issue":"5782","key":"140_CR8","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1126\/science.1124410","volume":"312","author":"S Gagneux","year":"2006","unstructured":"Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJM. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science. 2006;312(5782):1944\u20136.","journal-title":"Science"},{"issue":"1","key":"140_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.1038","volume":"44","author":"I Comas","year":"2012","unstructured":"Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-Maeda M, et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet. 2012;44(1):106\u201310.","journal-title":"Nat Genet"},{"issue":"1","key":"140_CR10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/oxfordjournals.bmb.a071952","volume":"40","author":"DA Mitchison","year":"1984","unstructured":"Mitchison DA. Drug resistance in Mycobacteria. Br Med Bull. 1984;40(1):84\u201390.","journal-title":"Br Med Bull"},{"issue":"3","key":"140_CR11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018327","volume":"6","author":"C Colijn","year":"2011","unstructured":"Colijn C, Cohen T, Ganesh A, Murray M. Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy. PLoS One. 2011;6(3), e18327.","journal-title":"PLoS One"},{"issue":"11","key":"140_CR12","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3201\/eid2011.130560","volume":"20","author":"AL Den Hertog","year":"2014","unstructured":"Den Hertog AL, Menting S, Van Soolingen D, Anthony RM. Mycobacterium tuberculosis Beijing genotype resistance to transient rifampin exposure. Emerg Infect Dis. 2014;20(11):1932\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"140_CR13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/thx.2010.148585","volume":"66","author":"KC Chang","year":"2011","unstructured":"Chang KC, Leung CC, Grosset J, Yew WW. Treatment of tuberculosis and optimal dosing schedules. Thorax. 2011;66(11):997\u20131007.","journal-title":"Thorax"},{"issue":"1","key":"140_CR14","first-page":"10","volume":"2","author":"DA Mitchison","year":"1998","unstructured":"Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 1998;2(1):10\u20135.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"6","key":"140_CR15","first-page":"939","volume":"121","author":"A Jindani","year":"1980","unstructured":"Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1980;121(6):939\u201349.","journal-title":"Am Rev Respir Dis"},{"key":"140_CR16","first-page":"273","volume":"31","author":"JB Selkon","year":"1964","unstructured":"Selkon JB, Devadatta S, Kulkarni KG, Mitchison DA, Narayana AS, Nair CN, et al. The emergence of isoniazid- resistant cultures in patients with pulmonary tuberculosis during treatment with isoniazid alone or isoniazid plus PAS. Bull World Health Organ. 1964;31:273\u201394.","journal-title":"Bull World Health Organ"},{"issue":"12","key":"140_CR17","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1086\/518046","volume":"195","author":"DA Mitchison","year":"2007","unstructured":"Mitchison DA, Jindani A, Davies GR, Sirgel F. Isoniazid activity is terminated by bacterial persistence. J Infect Dis. 2007;195(12):1871\u20132. author reply 1872\u20133.","journal-title":"J Infect Dis"},{"issue":"1","key":"140_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0032-1333544","volume":"34","author":"A Vernon","year":"2013","unstructured":"Vernon A. Treatment of latent tuberculosis infection. Semin Respir Crit Care Med. 2013;34(1):67\u201386.","journal-title":"Semin Respir Crit Care Med"},{"issue":"Suppl 3","key":"140_CR19","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1086\/321837","volume":"33","author":"SB Levy","year":"2001","unstructured":"Levy SB. Antibiotic resistance: consequences of inaction. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;33 Suppl 3:S124\u20139.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"140_CR20","unstructured":"3d APR Union conference 8\u201311 July 2011, Hong Kong. WHO the STOP TB department. http:\/\/www.antitb.org.hk\/apr2011\/8th%20july\/Plenary%20lecture%20I\/pl1_Global%20epidemiology%20of%20tuberculosis,%20past,%20present%20and%20future.pdf . Accessed June 2015."},{"issue":"5","key":"140_CR21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005602","volume":"4","author":"H Ayles","year":"2009","unstructured":"Ayles H, Schaap A, Nota A, Sismanidis C, Tembwe R, De Haas P, et al. Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One. 2009;4(5), e5602.","journal-title":"PLoS One"},{"issue":"1","key":"140_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2471\/BLT.08.055467","volume":"88","author":"EL Corbett","year":"2010","unstructured":"Corbett EL, Zezai A, Cheung YB, Bandason T, Dauya E, Munyati SS, et al. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ. 2010;88(1):13\u201321.","journal-title":"Bull World Health Organ"},{"key":"140_CR23","unstructured":"Shapiro A, Golub JA. Systematic review of active case-finding strategies in risk groups for tuberculosis (TB) and the relationship to the number needed to screen; report to WHO. 2012. http:\/\/www.who.int\/tb\/Review3NNS_case_active_TB_riskgroups.pdf . Accessed September 2015."},{"key":"140_CR24","unstructured":"Systematic Screening for Active Tuberculosis: Principles and Recommendations. Geneva: World Health Organization; 2013. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK294083\/ . Accessed June 2015."},{"key":"140_CR25","unstructured":"Hoog AH van\u2019t, Langendam MW, Mitchell E, Cobelens FG, Sinclair D, Leeflang MMG, et al. A systematic review of the sensitivity and specificity of symptom and chest radiography screening for active pulmonary tuberculosis in HIV negative persons and persons with unknown HIV status. WHO. 2013. http:\/\/www.who.int\/tb\/Review2Accuracyofscreeningtests.pdf?ua=1 . Accessed September 2015."},{"issue":"5","key":"140_CR26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1164\/rccm.200305-714OC","volume":"169","author":"RM Warren","year":"2004","unstructured":"Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, Van Pittius NC G, et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med. 2004;169(5):610\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"140_CR27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001739","volume":"6","author":"E Cambau","year":"2012","unstructured":"Cambau E, Chauffour-Nevejans A, Tejmar-Kolar L, et al. Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test. PLoS Negl Trop Dis. 2012;6, e1739.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-016-0140-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T11:53:32Z","timestamp":1600516412000},"score":1,"resource":{"primary":{"URL":"http:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-016-0140-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1186\/s40249-016-0140-y","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]},"article-number":"46"}}